Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04774029 · ClinicalTrials.gov registry record · Early Phase 1
Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management
A Early Phase 1 study of Vertebral Fracture and Vertebral Compression, sponsored by Northwell Health.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04774029: Completed Early Phase 1 study of Vertebral Fracture and Vertebral Compression, sponsored by Northwell Health.
NCT04774029 is a Early Phase 1 study of Vertebral Fracture and Vertebral Compression that has completed, run by Northwell Health. The registered enrollment target is 10 participants, below the 39-participant average among 3 other Vertebral Fracture trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04774029, a Early Phase 1 study of Vertebral Fracture and Vertebral Compression, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the efficacy of lidocaine basivertebral nerve block as intraprocedural anesthesia during vertebral augmentation procedures.
Primary Outcome
Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. VAS pain scores will be obtained upon preprocedural consultation.
Conditions Studied
Interventions
- PROCEDURE Basivertebral nerve block
- DRUG Lidocaine induced basivertebral nerve block
Study Locations (1)
New York
- Northwell Health Mather Hospital - Port Jefferson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2020-05-01 |
| Phase | Early Phase 1 |
What the finished NCT04774029 record still lists
NCT04774029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 39-participant average among 3 other Vertebral Fracture trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Vertebral Fracture appearing as the primary indexed condition, and to 2 interventions - of which Basivertebral nerve block is the first listed.
NCT04774029 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04774029 about?
NCT04774029 is a clinical study titled "Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management". The goal of this study is to assess the efficacy of lidocaine basivertebral nerve block as intraprocedural anesthesia during vertebral augmentation procedures.
What is the current status of trial NCT04774029?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2020-01-10. Estimated completion is 2020-05-01.
What conditions does trial NCT04774029 study?
This clinical trial studies the following conditions: Vertebral Fracture, Vertebral Compression, Vertebra Compression Fracture.
What interventions are being tested in trial NCT04774029?
The interventions under investigation include: Basivertebral nerve block (PROCEDURE), Lidocaine induced basivertebral nerve block (DRUG).
Who is sponsoring clinical trial NCT04774029?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04774029 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vertebral Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI